$16.82
-0.15-0.88%
At Close: -
$16.60
-0.22-1.31%
After Hours: 5:17 PM EDT
15 minutes delayed
Cartesian Therapeutics
RNACNASDAQ
Cartesian Therapeutics (RNAC) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCartesian Therapeutics (NASDAQ:RNAC) Stock Quotes, Forecast and News Summary
Cartesian Therapeutics Stock (NASDAQ: RNAC) stock price, news, charts, stock research, profile.
| Open | $16.87 |
| Close | $16.82 |
| Volume / Avg. | 613.97K / 143.21K |
| Day Range | 16.06 - 19.06 |
| 52 Wk Range | 11.67 - 42.60 |
| Market Cap | $354.56M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 14.54% |
| Days to Cover | 9 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cartesian Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTO...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cartesian Therapeutics (RNAC) stock?
You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.
Who are Cartesian Therapeutics (RNAC) competitors?
Other companies in Cartesian Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Cartesian Therapeutics (RNAC) stock?
There is no analysis for Cartesian Therapeutics.
What is the forecast for Cartesian Therapeutics (RNAC) stock?
Cartesian Therapeutics has a consensus price target of $35.50.
Current stock price for Cartesian Therapeutics (RNAC)?
The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $16.6 last updated Today at July 8, 2024 at 5:17 PM EDT.
Does Cartesian Therapeutics (RNAC) pay a dividend?
There are no upcoming dividends for Cartesian Therapeutics.
When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?
Cartesian Therapeutics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Cartesian Therapeutics (RNAC) going to split?
There is no upcoming split for Cartesian Therapeutics.
What sector and industry does Cartesian Therapeutics (RNAC) operate in?
Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.